# An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels

> **NCT02052986** · PHASE2 · UNKNOWN · sponsor: **New York Hospital Queens** · enrollment: 100 (estimated)

## Conditions studied

- Dyslipidemia

## Interventions

- **OTHER:** VASCAZEN

## Key facts

- **NCT ID:** NCT02052986
- **Lead sponsor:** New York Hospital Queens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052986, "An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02052986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*